Immune response against SARS-CoV-2 and seroprevalence surveys
In this session, we will discuss natural immunity against SARS-CoV-2 infections, serological testing and learn from the experience of South Sudan and Bosnia and Herzegovina on deployment of surveys. seroprevalence.
We will welcome:
Dr Lorenzo Subissi (WHO Headquarters, Geneva): An update on natural immunity to COVID-19
Dr Isabel Bergeri (WHO Headquarters, Geneva): Unity Studies, a global sero-epidemiological standardization initiative
Dr Joseph Wamala (WHO South Sudan Country Office): Severe Acute Respiratory Syndrome Coronavirus 2 IgG Seroprevalence in Juba, South Sudan, 2020: Experiences and Lessons Learned
Professor Dejan Bokonjić (University of Sarajevo East) Seroprevalence of COVID-19 infections in the population of Republika Srpska
Webinar presented in English, with simultaneous interpretation into Arabic, French, Portuguese, Russian and Spanish.
Launched in May 2020, this knowledge-sharing platform aims to improve the dissemination of WHO guidance and the sharing of best practices among public health laboratories around the world. This WHO platform contributes to the activities of the ACT-Accelerator Diagnostics pillar by enabling country preparedness. It is funded by the European Commission CBRN Centers of Excellence Initiative.